Life Sciences
Asia-Pacific Guide 2024 : Asia-Pacific Region
Band 2
Contact number
+852 3664 6488About
Provided by Ropes & Gray LLP
Today’s life sciences industry faces myriad challenges, including complex regulation, steep competition and ever-changing technologies. Companies around the world turn to Ropes & Gray’s global life sciences group for internationally recognized counsel on virtually all matters impacting their businesses.
We work across practices and geographies to develop cutting-edge solutions that help our clients meet their business goals.
In addition to advising biotechnology, pharmaceutical and medical device companies, we also work with:
Investment banks, venture capital and private equity firms, royalty monetization firms, private investment and hedge funds, and individual investors focused on funding life sciences-related companies
Food, dietary supplement, cosmetics and consumer product companies
Academic medical centers and research institutions
Veterinary, agricultural and industrial applications
Drawing on resources in our offices around the globe, we focus on developing cutting-edge solutions to help clients meet their business goals. Our practice includes:
Mergers & acquisitions
Licensing, collaborations & joint ventures
Public and private financings and SEC compliance
FDA regulatory and health care compliance
China regulatory & compliance
Government enforcement / white collar crime
Intellectual property
Securities & futures enforcement
Antitrust
Tax
To learn more about our practice, please visit: https://www.ropesgray.com/practices/life-sciences.aspx
Chambers Review
Ropes & Gray has impressively broad coverage of cross-border investments, licensing, corporate and compliance matters, especially those relating to the FCPA. The firm is prominent for its core expertise in transactional and regulatory matters, particularly the Shanghai and Hong Kong offices, while the Seoul team is notable for its IP expertise. It has experience in handling cross-border licensing and commercialisation agreements and leverages its capital markets expertise to act on IPOs and other related matters for clients in this industry. The firm retains a standout client roster of multinational biotech, pharmaceutical and healthcare companies and draws upon the support of US colleagues to advise on inbound and outbound transactions.
Arthur Mok and Katherine Wang in Shanghai are key contacts for clients.
Work Highlights
- Ropes & Gray advised Pediatrix Therapeutics on its licensing agreement with Aclaris Therapeutics to develop and commercialise ATI-1777 in China.
Strengths
Provided by Chambers
"Ropes & Gray is well positioned to help us navigate the regulatory differences, bridge the gaps and close the deals. The team can provide practical and constructive advice."
"Ropes & Gray is well positioned to help us navigate the regulatory differences, bridge the gaps and close the deals. The team can provide practical and constructive advice."